AzTrials
AzTrials

Prosthesis DurabilityPROLIMBNCT05220553

A Sensorimotor Prosthesis for the Upper Limb

A study testing PROLIMB Prosthesis in people with Prosthesis Durability and Prosthesis User, run by University Hospitals Coventry and Warwickshire NHS Trust at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The finger and fingertip are the most frequently amputated body parts, due to work-related incidents. Yet because of space, weight and cost constraints, prosthetic fingers and fingertips are heavy and bulky with limited active motion and sensation. Most are basic variations on the hook and claw. Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Prosthesis Durability, Prosthesis User, Amputation
What is being tested?
PROLIMB Prosthesis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4 participants
Where
1 siteUnited Kingdom
Study dates
10 Jul 2023to 16 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 18 or older
  • Had a previous unilateral finger/thumb digit(s) amputated (through accident or surgery) within the 12 months before consenting into the PROLIMB II study.
  • Amputated distal to proximal phalange/metacarpal joint
  • Have capacity to provide informed consent

Who cannot join

  • Have been frequently using an alternative prosthetic for their digit amputations for over 1 month.
  • Still receiving active treatment or rehabilitation or healing for their residual digits at the time of screening.
  • Patients who are amputated at or proximal to the proximal phalange/metacarpal joint.
  • Allergic or hypersensitive to the material in contact with the skin
  • Evidence of neuroma causing point hypersensitivity

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University Hospital Coventry and Warwickshire NHS Trust

    Coventry, West Midlands, CV22DX

Other trials in United Kingdom

About this study

Official title: A Sensorimotor PROsthesis for the Upper LIMB

The finger and fingertip are the most frequently amputated body parts, due to work-related incidents. Yet because of space, weight and cost constraints, prosthetic fingers and fingertips are heavy and bulky with limited active motion and sensation. Most are basic variations on the hook and claw. Lower limb prostheses have become extremely technologically advanced in their design and materials, and upper limbs lag behind in all of these areas. This is due to the complexity of the anatomy and function of the upper limb compared to the lower. There are no commercially available prostheses that offers direct sensory feedback and as such, rely on visual feedback from the wearer.

The original PROLIMB study (PROLIMB I) used a Leap Motion Controller (LMC) to investigate the type of grasp adaptation that have been undertaken by patients during the rehabilitation process following amputation and compared this to similar data from healthy volunteers. PROLIMB I also looked at refining the tactile feedback system by investigating the sensation felt on amputation sites in order to feed this information into the haptic feedback system.

The vision of the PROLIMB II project is to build on the work completed in PROLIMB I and develop and combine mechanistic models of hand motion and haptic sensing to deliver novel, affordable body-powered prosthetic fingertip digits with enhanced motion and sensation to address current clinical needs and support the quality of life of amputees. With collaboration from the University of Warwick (UoW) and University College London (UCL), Steeper Group and Naked Prosthetics the PROLIMB II study will aim to model, design, fabricate and validate a body-powered prosthetic fingertip digit with integrated sensory feedback. The University Hospital Coventry \& Warwickshire (UHCW) will provide the clinical facility with which to assess the comfort, usability and acceptance of this prosthetic in the daily lives of patients with digit amputations. This project will be a proof of concept study with verification of the prosthetic in motion capture (gait) laboratories as well as the use of simple validation data collection over a longer period.

Read the detailed description

Worldwide, there are about 3 million upper limb amputees - 80% of these people live in low-income countries. Only 2% have access to prosthetic care. The World Health Organization and Prosthetics Outreach Foundation identified a number of reasons why patients in low-income countries do not have access to prosthetics: lack of trained personnel, frequent replacement and repair (prosthetic replacement is needed typically every 6-12 months for children and every 3-5 years for adults). This problem is not limited to developing countries: in the UK, the prostheses available from the National Health Service (NHS) have either a greatly simplified choice of actions available or are too expensive to be routinely funded.

Upper-limb amputees suffering from traumatic injuries require long-term, frequent intensive medical care (work-related injuries cause the highest number of days away from work) and psychological support. NHS England spends approximately £60m/year on services for patients. Current prostheses are limited to cosmetic devices that fail to recover the original functionality of the hand. Up to 20% of the adult population with upper limb amputations choose not to use a prosthesis (Biddiss \& Chau, 2017) - the prescribed device is discarded as it is often seen as an obstacle. Of those that do accept a prosthesis, 26% of adults and 45% of children and adolescents are dissatisfied with their device and choose not to use them (NHS England, 2015). Hence, the NHS effectively does not provide service to over 50% of upper-limb amputees. Reasons cited include poorly developed fine motor control, absence of sensory function, weight and a lack of warmth and humanness.

Currently the NHS is working in collaboration with companies who uitilize 3D printing technology to dramatically reduce the waiting time and costs of custom prosthetic hands. Open Bionics' Brunel Hand is a simple myoelectric (using the electrical signals from the muscle) control hook in the form of a human hand (open bionics, 2018). Although it is low-cost (£1200) and at a price point that the NHS may fund, there are still areas in which it could be improved, such as providing sensory feedback to the user. At present, the only form of feedback that upper limb prostheses provide is visual, rather than tactile. As such, the user must be able to see the prosthesis in order to use it effectively. A body powered prosthesis with more grasps and therefore more functionality would also be preferred.

Body powered prosthetic devices are considered to have many advantages over myoelectric devices due to their robust, rugged and predictable nature. Other companies currently developing upper-limb prostheses include Touch Bionics, RSL Steeper, Ottobock and Defence Advanced Research Projects Agency (DARPA). The prosthetic devices created by these companies are much more expensive (approximately £20,000 - £75,000). All require an extrinsic power source (e.g. battery) and with high complexity comes high maintenance and risk of failure. None of the available prosthesis described provide any discrete tactile feedback.

Although sensory information can be relayed to patients via direct integration with the central nervous system (Yildiz, et al., 2020), it is safer and simpler to provide this via haptic feedback. A body-powered hydro elastic haptic sensor has been developed and can relay fine sensory information from the tip of a prosthetic finger to an actuator that is in direct contact with the sensate residual limb. Although the resolution of the sensitivity in the residual limb is reduced (for example there is reduced ability to resolve between two discrete points of contact), the actual light touch sensation is retained after injury (e.g. on the residual palm or forearm). The haptic sensor and actuator can also amplify the signal to improve sensitivity.

To design a body-powered sensory upper limb prosthesis, the action of the uninjured hand must be fully appreciated. The hand requires function over form, rather than vice versa. Although the visual appearance of a hand may be preferential, this can limit the design and capabilities of the prosthesis.

Combining the synergetic expertise in developing parameterised mathematical models of limb motion from the UoW and in creating soft, stiffness-controllable robotic structures, and haptic feedback interfaces from UCL, the aim of this project is to model, design, fabricate and validate a body-powered prosthetic fingertip digit with integrated mechanical haptic feedback. Of key importance for the project's success is its transformative nature through close collaboration with experienced clinical experts from the UHCW and the UHCW Innovation Hub, who will offer consultation and clinical input throughout.

The PROLIMB II study is a single centre pilot study that will be testing the feasibility of the trial design when integrating a tactile haptic feedback mechanism into prostheses. The PROLIMB II study will utilise a pre-existing CE marked finger digit prostheses (Naked Prostheses) and a non-CE marked prosthesis that has been created and designed by UCL. The CE marked finger digit prostheses will be custom made and manufactured by Naked Prosthetics (NP) - a commercial company in the USA that distributes their custom-fabricated finger prostheses to the UK through a secondary company called Steeper Group (SG). The non-CE marked prosthesis will be designed and manufactured by PROLIMB II researchers at UCL The PROLIMB research team will modify the prostheses so that they provide participants with sensory feedback when touching objects at the fingertip (full details of the device and modifications can be found in section 1.3). Testing will also be conducted with the haptic feedback mechanism attached to the residual stump, in order to collect sensation data.

The study will recruit up to 10 participants. The total number of patients consented into the study may be greater than 10 as, following consent, NP are required to screen participants who will be receiving their prosthesis and so may deem some participants as unideal candidates for their prosthetic. If this occurs, participants will be offered the UCL prosthesis to use instead. Potential participants will have had one or more finger/thumb digits amputated through either accident or surgery within 1 year of consenting into the study. The wound will be completely healed at the point of consent and the prosthesis/haptic feedback system will not come into contact with an injured dermis. Potential participants will be identified by delegated individuals of the PROLIMB research team at University UHCW. If eligible, participants will be sent the study information pack and called to discuss the study further. If the participant is happy, they will be invited to take part in the study.

For those who are receiving prosthetic devices from NP, these are custom-made for each participant; therefore consented participants will then need to be screened by experts at NP. This will involve the participants completing a partial hand information form and sending photos and videos of the participant's hands showing their level of amputation and their current range of motion. No personal data will be shared with Naked Prosthetics and all photo's/videos will be pseudo-anonymised (linked to a unique participant ID) and only show the participants hands/arms.

If deemed suitable, devices will be custom made for participants and sent to UHCW for initial attachment and testing with the participant. Following this the prosthesis will be sent to collaborators at UCL who will modify the prosthetic to incorporate tactile haptic feedback into the fingertip and then returned to UHCW. The modified prosthetic will then be reattached to the participant and further testing will take place (details of testing procedures can be found in section 7.2). The prosthesis may also be supplied by UCL, further details of which can be found in section 1.3.2.

Testing will continue over the next 10 months and take place at bi-monthly (± 3 weeks) intervals at UHCW gait lab. Tests will be performed both with and without the PROLIMB II prosthesis attached. All performance tests will be conducted whilst the participant is recorded using a VICON Motion Capture System (VMCS). During each visit a series of questionnaires and interviews will also take place to collect data related to participant's satisfaction with the PROLIMB II prosthesis. At the end of the study, participants will have the option to keep the PROLIMB II prosthesis if they wish, however they will be made aware that this is without any form of warranty for the devices.

Being tested
PROLIMB Prosthesis
Medical subject headings
Prosthesis Failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PROLIMB ProsthesisDevice

    Participants will be given the PROLIMB prosthesis to test in the lab and to use in their daily lives

Study groups in NCT05220553
Study groupRoleWhat they receive
ProsthesisExperimentalParticipants will be given the PROLIMB II prosthesis to trial in our lab and in their daily lives
Receives: Device: PROLIMB Prosthesis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To test the feasibility of using the PROLIMB II prosthesis for patients who have suffered recent finger/thumb digit amputations

    Number of patients screened, recruited, withdrawn, retained and deemed suitable for using the PROLIMB II prosthesis.

    Measured: 24 months

Secondary outcomes (6)
  1. To demonstrate a difference in the performance when using the PROLIMB II prosthesis for simple daily motor tasks vs when completing without

    Number of participants who show a change in their motor function when using the YCB object and model set and Southampton Hand Assessment Procedure

    Measured: 24 months

  2. To show a change in the fine motor skills of participants during the study using the VICON Motion Capture System.

    Number of participants whose moments become more smooth and stable. 3D motion capture cameras and HD cameras will be used to finely track participants movements in order to quantify improvements in movement during routine tasks of the YCB model and object set and the Southampton Hand Assessment Procedure..

    Measured: 24 months

  3. Number of patients that show an acceptabilitys to use the PROLIMB II prosthesis in their daily lives using the QuickDASH questionnaire

    QuickDASH questionnaire at bi-monthly intervals

    Measured: 24 months

  4. Number of patients that show an acceptabilitys to use the PROLIMB II prosthesis in their daily lives using teh TAPES-R outcome measure

    TAPES-R outcome measure at bi-monthly intervals

    Measured: 24 months

  5. To show a change in the levels of sensation felt by the participant when using the prosthetic via the two point discrimination measure

    Two point discrimination for measurements of sensation

    Measured: 24 months

  6. To show a change in the levels of sensation felt by the participant when using the prosthetic via the mono filament test

    Mono filament tests for measurements of sensation

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Feb 2022
  2. Study start10 Jul 2023
  3. Primary completion16 Aug 2024
  4. Study completion16 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Feasibility Pilot Study
Masking
None (open label)
Enrolment
4 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05220553
Sponsor's protocol ID
JH596520
Acronym
PROLIMB
Status last verified
Mar 2025
First submitted
6 Jan 2022
Last updated
24 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing PROLIMB Prosthesis in people with Prosthesis Durability and Prosthesis User, run by University Hospitals Coventry and Warwickshire NHS Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To test the feasibility of using the PROLIMB II prosthesis for patients who have suffered recent finger/thumb digit amputations (time frame: 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in